Pyxis Oncology, Inc.
PYXS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $91,175 | $71,828 | $44,264 | $353,485 |
| - Cash | $19,473 | $9,664 | $179,293 | $274,735 |
| + Debt | $20,200 | $21,331 | $18,921 | $165 |
| Enterprise Value | $91,902 | $83,495 | -$116,108 | $78,915 |
| Revenue | $16,146 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $15,671 | $0 | $0 | $0 |
| % Margin | 97.1% | – | – | – |
| EBITDA | -$65,514 | -$80,269 | -$122,772 | -$69,070 |
| % Margin | -405.8% | – | – | – |
| Net Income | -$77,331 | -$73,790 | -$120,717 | -$75,975 |
| % Margin | -478.9% | – | – | – |
| EPS Diluted | -1.32 | -1.85 | -3.57 | -2.53 |
| % Growth | 28.6% | 48.2% | -41.1% | – |
| Operating Cash Flow | -$57,672 | -$70,709 | -$89,335 | -$35,326 |
| Capital Expenditures | -$237 | -$6,726 | -$6,399 | -$540 |
| Free Cash Flow | -$57,909 | -$77,435 | -$95,734 | -$35,866 |